H.C. Wainwright Assumes Galectin Therapeutics (GALT) at Buy
Tweet Send to a Friend
(Updated - June 17, 2025 6:34 AM EDT)
H.C. Wainwright analyst Matthew Keller assumes coverage on Galectin Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Matthew Keller assumes coverage on Galectin Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
